Abstract
Introduction
Prognostic factors for recurrent stroke or myocardial infarction (MI) in patients with a transient ischemic attack (TIA) or nondisabling stroke are clinically important because they help to identify patients in whom secondary prevention is particularly worthwhile and because they may be amenable to intervention.
We and others have investigated prognostic factors in large cohorts of patients by means of multiple regression techniques. 1 2 In both studies, relative risks were presented for each factor included in the final prediction model, but absolute risks and the dispersion of the risk estimates over the study population were not reported. Hankey et al, 3 however, reported the results of a prediction model for stroke or major vascular events based on a small cohort of 469 patients with a TIA. The model was validated on a sample of 1653 patients in the UK TIA Trial and on 107 patients in the Oxfordshire Community Stroke Project. 4 They concluded that most prognostic factors were weak and consequently that patients at high risk could not reliably be identified. We wondered whether these conclusions would hold in more detailed, previously published multiple regression models based on data from 3127 patients in the Dutch TIA Trial. 
Subjects and Methods
In the Dutch TIA Trial, a multicenter, double-blind study of low-dose (38 mg) versus mediumdose (283 mg) aspirin, 3127 patients were included within 3 months after onset of a TIA, amaurosis fugax, or nondisabling stroke. Recorded baseline characteristics included neurological history, vascular risk factors and prior vascular diseases, the results of CT scanning of the brain, and a standard 12-lead electrocardiogram. Outcome events were vascular death, MI, and stroke, the definitions of which have been described elsewhere. 5 In a previous study we developed a prediction model by means of Cox proportional hazards regression for the composite outcomes of "fatal or nonfatal stroke" and for "myocardial infarction, stroke, or vascular death," whichever came first. 1 For each composite outcome a prediction model was developed that was based on clinical and demographic information, as well as on the results of ancillary investigations such as CT and electrocardiography. The two models contained 13 and 16 prognostic factors, respectively, all of which were statistically significant. The relative risks associated with these factors were typically in the range between 1 and 2 (Table  ) , but a patient with all risk factors present would have a more than 99% risk of an outcome event. In the present study we examined the aggregation of prognostic factors in this study population, the discriminatory power of the two prediction models by means of receiver operating characteristic analysis, and the calibration (ie, the concordance of the predicted probabilities with observed probabilities) of the models.
6
Results
This analysis concerns the 3126 patients who were entered into the Dutch TIA Trial and had complete baseline information. A stroke occurred in 272 patients and was fatal in 57. Two hundred patients had a major cardiac event (nonfatal MI in 67, sudden death in 84, and other cardiac death in 49). The combined outcome of stroke, MI, or vascular death (whichever came first) occurred in 469 patients. The 2-year risk of stroke was 7.2% (95% confidence interval [CI], 6.3% to 8.2%), and the 2-year risk of stroke, MI, or vascular death was 11.8% (95% CI, 10.7% to 13.0%), estimated by Kaplan-Meier survival analysis. The calibration of the two models was reasonable in the range of probabilities lower than 40%. The proportion of patients with a predicted probability exceeding 30% was less than 5% for both models; in this respect the calibration of the models was poor (Fig 1 ) . The median number of prognostic factors for stroke, MI, or vascular death outcome was 3, and in only 2.5% of the patients were more than 6the patients with stroke was given such a high probability. The discriminatory ability of the models was disappointing (Fig 2 ) . 
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Discussion
When the evaluation of any prediction model is based on the data from which the model was derived, the results tend to be overoptimistic. Nevertheless, the calibration and discriminatory power of our prediction models for recurrent stroke and vascular events in patients with a recent TIA or nondisabling stroke, based on more than 3000 patients and several hundreds of outcome events occurring during more than 2 years of follow-up, was less than satisfactory. Further external validation is therefore not necessary to prove our main conclusion that we need stronger predictors of major outcome events in patients with a TIA or nondisabling stroke. This rather disappointing result can be explained by the fact that most patients had no more than three or four relatively weak prognostic factors, in combination with the low baseline risk. We tested for the presence of complex interactions in the data, but the relative risk of each of the two outcomes increased linearly with the number of predictors present in each patient, with a factor of 1.4 (95% CI, 1.3 to 1.5) for stroke, MI, and vascular death and a factor of 1.5 (95% CI, 1.4 to 1.7) for fatal and nonfatal stroke, which are equal in magnitude to the relative risks associated with the individual predictors.
The patients in this study constitute a selected sample of all patients with a TIA or nondisabling stroke because they had been entered into a randomized clinical trial. Thus, most patients who were candidates for endarterectomy because they had a severe symptomatic carotid stenosis were excluded from this sample. We therefore did not take carotid stenosis and plaque morphology into account. 7 Nevertheless, this analysis shows that we need stronger predictors of risk of recurrence. To be clinically useful, such prognostic information should be easily obtainable at low cost and at low risk to the patient. In our opinion, potentially useful prognostic factors that deserve further prospective evaluation may be provided by transcranial Doppler monitoring, 8 carotid intima-media thickness, 9 coagulation disturbances, 10 and transesophageal echocardiography. 11 12 13 
